In-vitro Transcription Templates Market to Perceive Substantial Growth During 2026
Read Report Overview @ https://www.transparencymarketresearch.com/in-vitro-transcription-templates-market.html
Rise in focus of health care and pharmaceutical companies in R&D, drug discovery, and gene editing has led to increase in demand for new and advanced transcription techniques to introduce new products and drugs in the pharmaceutical industry. This, in turn, is driving the global in-vitro transcription templates market during the forecast period. Rise in adoption of personalized medicine by health care providers is expected to increase demand for in-vitro transcription templates. Introduction of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene editing technology, enabling targeted medicine using RNA to bind to specific targets, and increase in incidence of rare diseases are some drivers of the global in-vitro transcription templates market during the forecast period. However, requirement for large capital investment deters new entrants from entering the market. This has increased the bargaining power of manufacturers and is leading to high cost of the in-vitro transcription templates and restraining the adoption and subsequent expansion of the global in-vitro transcription templates market.
The global in-vitro transcription templates market is segmented on the basis of product type, application, end-user, and region. Based on product type, the global market is dived into plasmids, polymerase chain reaction (PCR) based products, oligonucleotides, and cDNA templates. The plasmids segment dominated the global in-vitro transcription templates market in 2017, owing to higher adoption of plasmids as templates by end-users. However, oligonucleotides segment is anticipated to expand at a considerable CAGR from 2018 to 2026. Expansion of the segment can be attributed to increase in application in research, therapeutics, and diagnostics of oligonucleotide templates. Base on application, the global in-vitro transcription templates market is segmented into drug discovery, structural studies, biochemical and genetic studies, and others. The drug discovery segment dominated the global market in 2017. In terms of end-user, the global in-vitro transcription templates market is segregated into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic & research institutes, and others. The pharmaceutical and biotechnology companies segment is expected to dominate the global market in 2017 due to high R&D focus and expenditure.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43415
Based on region, the global in-vitro transcription templates market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global in-vitro transcription templates market in 2017, and is expected to continue its dominance during the forecast period. Increase in focus of health care institutions toward personalized medicine and targeted drug delivery, high expenditure of pharmaceutical and biotechnology companies for R&D, and rise in government initiatives to promote drug discovery are some factors driving the market in North America. Europe accounted for the second largest share of the market in 2017, followed by Asia Pacific.
Key players operating in the global in-vitro transcription templates market include Bio-Synthesis Inc., Thermo Fisher Scientific, Promega Corporation, Lucigen, New England Biolabs, Takara Bio USA (a Takara Bio Company), Enzynomics co Ltd., Enzo Life Sciences, Inc., and Agilent Technologies
Request for Report TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43415
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-vitro Transcription Templates Market to Perceive Substantial Growth During 2026 here
News-ID: 1225226 • Views: 167
More Releases from Transparency Market Research
Molecular Weight Marker Market – Top Key Players and Industry Outlook
A molecular weight marker is used during electrophoresis on the gel, to identify the approximate size of the molecule. On the gel matrix, the principle used to identify the molecular weight is that the migration rate is inversely proportional to the molecular weight. Therefore, the effective logarithmic scale formed on the gel is used to estimate the size and weight of the unknown protein or DNA or RNA, provided that
Cell Washing Centrifuge Market Size Incredible Possibilities And Growth Analysis
Global Cell Washing Centrifuge Market: Overview The global cell washing centrifuge market is expected to ride along a lucrative pathway in the years to follow. Presence of an unchallenged research sector has played an integral role in driving sales across the global market. The medical industry has made ardent efforts to understand the composition of various types of cells in the body. This quest has led the industry to invest in
Recombinant Therapeutic Antibodies & Proteins Market Growth Trends, Current Dema …
Human proteins obtained through genetic engineering rather than from tissue samples have played a vital role in therapeutic medicines market. Advances in pharmacological understanding and pharmaceutical production have allowed continuous development of human proteins as a vital therapeutic option in variety of human diseases. From a clinical perspective, therapeutic proteins provide essential therapies in various life threatening disease such as diabetes, viral hepatitis, end-stage renal disease, clotting disorders and other
Polymeric Nanoparticles Market In-depth Analysis, Business Strategies, and Growt …
Polymeric nanoparticles consist of polymers having nanoparticles dispersed in the matrix. This dispersion is done by in-situ polymerization and melt compounding technology which results in enhanced properties of the material. Polymeric nanoparticles possess properties such as high heat resistance, high electrical conductivity and enhanced dimensional stability. The major applications include automobile, electronics, aerospace, food packaging, pharmaceuticals and healthcare. Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3229 Growing automotive industry is expected to drive
More Releases for RNA
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led